Company intelligence / Profile preview

Temasek

Ownership: Private
Employees: ~900
Development stage: Other

Overview

Temasek is a Singaporean state-owned global investment company with S$389 billion (~US$288 billion) in assets under management as of March 2024. It invests across multiple sectors including life sciences and healthcare, but does not itself develop drugs or medical products. Its compounded annualized total shareholder return since inception in 1974 is 14%.

Industry: Investors

Partnerships

Investments/co-investments with GIC and TPG Asia

Beyond the preview

Go deeper on Temasek.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Temasek.

Explore the full profile